Executive Summary
HHS awarded $297.6M in obligations across three contracts, with bullish signals for General Dynamics and Deloitte in healthcare IT services amid high outlays ($206.8M total) signaling revenue stability. Potential value exceeds $715M if options exercised, concentrated in CMS, NIH, and CDC. Neutral nonprofit award to SUNY limits public market impact but underscores HHS clinical services spend.
Tracking the trend? Catch up on the prior All HHS Contracts digest from March 04, 2026.
Investment Signals(2)
- HHS IT Services Revenue Ramp(HIGH)β²
GD and Deloitte secure $231M obligated with $175M outlayed in CMS/NIH IT contracts, indicating locked-in cash flows through 2027+.
- Nonprofit Clinical Services Flow(HIGH)β²
SUNY Foundation's $66M CDC award for clinical centers shows steady HHS healthcare spend but no direct public equity exposure.
Risk Flags(2)
- Execution[HIGH RISK]βΌ
Heavy subaward reliance ($193M across 146 subs) creates performance dependencies in GD/Deloitte contracts.
- Market[MEDIUM RISK]βΌ
Long tenors to 2031 expose all to HHS budget shifts or unexercised options ($418M at risk).
Opportunities(2)
- β
$418M in unexercised options across contracts, with GD's $331M ceiling offering largest upside.
- β
HHS prioritization of IT hosting/UCC and clinical excellence signals multi-year sector tailwinds.
Sector Themes(2)
- β
Two-thirds of value ($231M) in CMS/NIH IT delivery orders highlights demand for systems design and unified comms.
- β
CDC's $66M+ clinical centers award reflects sustained public health services funding.
Watch List(3)
- π
{"entity"=>"General Dynamics (GD)", "reason"=>"Largest obligation ($146M) with $476M ceiling and 77% outlay rate signals multi-year revenue base.", "trigger"=>"Option exercise announcements >$100M"}
- π
{"entity"=>"Deloitte", "reason"=>"$86M NIH award with $6M options remaining amid high outlay pace.", "trigger"=>"Q1 2027 outlay acceleration"}
- π
{"entity"=>"HHS IT Subawards", "reason"=>"$193M across 146 subs may flow to tier-2 providers.", "trigger"=>"Subawardee disclosures in 10-Ks"}
Get daily alerts with 2 investment signals, 2 risk alerts, 2 opportunities and full AI analysis of all 3 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC